【レポートの概要（一部）】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: PIPELINE
PART 07: MARKET SEGMENTATION BY TYPE
• Market segmentation by type
• Comparison by type
• Intrahepatic cholangiocarcinoma – Market size and forecast 2018-2023
• Extrahepatic cholangiocarcinoma – Market size and forecast 2018-2023
• Market opportunity by type
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• Pfizer Inc.
• Sanofi
PART 14: APPENDIX
• Research methodology
• List of abbreviations
Exhibit 01: Global oncology therapeutics market
Exhibit 02: Segments of global oncology therapeutics market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market
Exhibit 08: Global market
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: Global cholangiocarcinoma therapeutics market pipeline
Exhibit 18: Global cholangiocarcinoma therapeutics market pipeline
Exhibit 19: Type – Market share 2018-2023 (%)
Exhibit 20: Comparison by type
Exhibit 21: Intrahepatic cholangiocarcinoma – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Intrahepatic cholangiocarcinoma – Year-over-year growth 2019-2023 (%)
Exhibit 23: Extrahepatic cholangiocarcinoma – Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Extrahepatic cholangiocarcinoma – Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by type
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America – Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 36: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Bristol-Myers Squibb Company – Vendor overview
Exhibit 46: Bristol-Myers Squibb Company – Business segments
Exhibit 47: Bristol-Myers Squibb Company – Organizational developments
Exhibit 48: Bristol-Myers Squibb Company – Geographic focus
Exhibit 49: Bristol-Myers Squibb Company – Key offerings
Exhibit 50: Bristol-Myers Squibb Company – Key customers
Exhibit 51: Eli Lilly and Company – Vendor overview
Exhibit 52: Eli Lilly and Company – Business segments
Exhibit 53: Eli Lilly and Company – Organizational developments
Exhibit 54: Eli Lilly and Company – Geographic focus
Exhibit 55: Eli Lilly and Company – Segment focus
Exhibit 56: Eli Lilly and Company – Key offerings
Exhibit 57: Eli Lilly and Company – Key customers
Exhibit 58: F. Hoffmann-La Roche Ltd – Vendor overview
Exhibit 59: F. Hoffmann-La Roche Ltd – Business segments
Exhibit 60: F. Hoffmann-La Roche Ltd – Organizational developments
Exhibit 61: F. Hoffmann-La Roche Ltd – Geographic focus
Exhibit 62: F. Hoffmann-La Roche Ltd – Segment focus
Exhibit 63: F. Hoffmann-La Roche Ltd – Key offerings
Exhibit 64: F. Hoffmann-La Roche Ltd – Key customers
Exhibit 65: Pfizer Inc. – Vendor overview
Exhibit 66: Pfizer Inc. – Business segments
Exhibit 67: Pfizer Inc. – Organizational developments
Exhibit 68: Pfizer Inc. – Geographic focus
Exhibit 69: Pfizer Inc. – Segment focus
Exhibit 70: Pfizer Inc. – Key offerings
Exhibit 71: Pfizer Inc. – Key customers
Exhibit 72: Sanofi – Vendor overview
Exhibit 73: Sanofi – Business segments
Exhibit 74: Sanofi – Organizational developments
Exhibit 75: Sanofi – Geographic focus
Exhibit 76: Sanofi – Segment focus
Exhibit 77: Sanofi – Key offerings
Exhibit 78: Sanofi – Key customers
Exhibit 79: Validation techniques employed for market sizing
【レポート販売概要】
■ タイトル：胆管癌治療薬の世界市場2019-2023■ 英文：Global Cholangiocarcinoma Therapeutics Market 2019-2023
■ 発行日：2019年2月23日
■ 調査会社：Technavio
■ 商品コード：IRTNTR30865
■ 調査対象地域：グローバル、アジア、北米、ヨーロッパ（EMEA）
- ディスクリートコンデンサの世界市場：セラミックコンデンサー、アルミコンデンサ、紙・プラスチックAC&DCフィルムコンデンサ、タンタルコンデンサAbout Discrete Capacitors A normal form of a capacitor is a one that preserves and discharges electrical energy without any loss of energy. A discrete capacitor, on the other hand, can have losses of electric current due to the nature of its capacitor components. Discrete capacitors can be made of different materials such as ceramic or plastic dielectric and also have different types of build-up d …
- フタル酸ジイソブチル(DIBP)の世界市場Di-isobutyl Phthalate(DIBP) (CAS 84-69-5) Market Research Report 2014 presents comprehensive data on di-isobutyl phthalate(DIBP) markets globally and regionally (Europe, Asia, North America etc.) The report includes di-isobutyl phthalate(DIBP) description, covers its application areas and related patterns. It overviews di-isobutyl phthalate(DIBP) market, names di-isobutyl phthalate(DIBP) producers …
- 世界の医療用セラミック市場動向（2012-2016）TechNavio’s analysts forecast the Global Medical Ceramics market to grow at a CAGR of 4.25 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing demand for cosmetic dentistry. The Global Medical Ceramics market has also been witnessing its application in hip replacement implants. However, threat of brand loyalty to small companies could pose a …
- 肝性脳症(Hepatic Encephalopathy)：世界の治験レビュー（2015年上半期版）Hepatic Encephalopathy Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hepatic Encephalopathy Global Clinical Trials Review, H1, 2015" provides data on the Hepatic Encephalopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatic Encephalopathy. It includes an overview of the trial numbers and …
- Hyperthyroidism：グローバル臨床試験レビューH2, 2013Hyperthyroidism Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Hyperthyroidism Global Clinical Trials Review, H2, 2013" provides data on the Hyperthyroidism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperthyroidism. It includes an overview of the trial numbers and their recruitment status as …
- Emera Inc.：発電所及びSWOT分析2013Emera Inc. - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized and detailed …
- セザリー症候群(Sezary Syndrome)：世界の治験レビュー（2015年上半期版）Sezary Syndrome Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Sezary Syndrome Global Clinical Trials Review, H1, 2015" provides data on the Sezary Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sezary Syndrome. It includes an overview of the trial numbers and their recruitment status as …
- 季節性アレルギー性鼻炎(Seasonal Allergic Rhinitis)の治療薬パイプライン動向（2015年上半期版）Seasonal Allergic Rhinitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Seasonal Allergic Rhinitis - Pipeline Review, H1 2015’, provides an overview of the Seasonal Allergic Rhinitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Seasonal Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics …
- 世界の蛍石市場：市場規模、動向、メーカー動向Scope The report presents a thorough study of fluorspar, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing fluorspar production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: fluorspar p …
- オンハイウェイ車両向けディーゼルパーティキュレートフィルターの世界市場予測（～2025年）“Increasing focus on emission regulation is expected to fuel the demand for diesel particulate filter”The OE DPF market is projected to grow at a CAGR of 11.29% during the forecast period and is projected to reach a market size of USD 24.81 billion by 2025, from an estimated market size of USD 10.55 billion in 2018. The DPF aftermarket is projected to grow at a CAGR of 3.89% during the forecast pe …
- 自動車用軽量素材の世界市場：金属、プラスチック、複合材About Automotive Lightweight Materials Automotive lightweight materials are of lower density than traditional automotive materials, such as iron and steel. The lightweight materials have a wide range of applications in automobiles because they not only help to reduce the weight of the vehicles, but also aid in providing enhanced automotive safety and fuel efficiency. The common lightweight materia …
- 栄養補助食品の世界市場：機能性飲料、機能性食品、ダイエットサプリメントAbout Nutraceuticals The term "nutraceutical" was coined from the words "nutrition" and "pharmaceutical," by Stephen Defelice, in 1989. Defelice was the founder and chairman of the Foundation for Innovation in Medicine, an American organization that encourages medical health discovery. A nutraceutical substance is any food, or part of a food, that provides medical or health benefits and helps in t …
- AES SONEL S.A.：発電所及びSWOT分析2013AES SONEL S.A. - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized and deta …
- インメモリーコンピューティングの世界市場：IMDM（データ管理）、IMAP（アプリケーションプラットフォーム）、IMDB、IMDG、OLAP、OLTPIn-memory processing has been gaining popularity due to the drop in computer memory prices, exponential data growth, and an increasing trend toward using analytics for decision making. Business of all sizes and across all industries can benefit from the cost savings obtainable through the in-memory technology. The global In-Memory Computing (IMC) market is expected to grow from USD 5.58 billion in …
- Amblyopia：グローバル臨床試験レビューH1, 2013Amblyopia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Amblyopia Global Clinical Trials Review, H1, 2013" provides data on the Amblyopia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Amblyopia. It includes an overview of the trial numbers and their recruitment status as per the site of trial c …
